Press & Earned Media

Pitches, exclusives, embargoes, and measurement of coverage quality.

  • 4 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Press & Earned Media


chop.edu > centers-programs > billing-and-insurance > does-chop-take-my-insurance

Does CHOP take my insurance?

44+ min ago   (1487+ words) If you are not sure if your child's visit will be covered, call your insurance company to find out about your plan, referrals, authorizations, copays and more. Children's Hospital of Philadelphia, its affiliated physician groups and its Home Care department…...


thebusinessdesk.com > scotland > news > 8124-retail-tech-firm-secures-seven-figure-virgin-money-facility-as-transaction-volumes-across-platform-hit-record-levels

Retail tech firm secures seven-figure Virgin Money facility as transaction volumes across platform hit record levels

38+ min ago   (171+ words) Dundee-founded retail technology company Snappy Group has secured a seven-figure funding facility from Virgin Money as transaction volumes across its platform hit record levels. The venture debt facility will support the Scottish scale-up’s expansion across its retail technology and marketplace…...


appliedclinicaltrialsonline.com > view > flexible-clinical-operations-site-management-quality-design-risk-based-oversight

Flexible Clinical Operations and Site Management Across a Diversified Biotech Portfolio: An Application of Quality by Design and Risk-Based Oversight

1+ hour, 24+ min ago   (711+ words) How a phased CRO partnership built on ICH E6(R2) and E6(R3) principles supported a multi-indication biotech portfolio. Regulatory authorities, including the International Council for Harmonization (ICH), the FDA, and the European Medicines Agency (EMA), have emphasized the importance of risk‑based approaches,…...


forbes.com > sites > nathanvardi > 06/11/2015 > the-29-year-old-behind-the-giant-biotech-ipo-that-rose-by-75-speaks

The 29 Year Old Behind The Giant Biotech IPO That Rose By 90% Speaks

6+ day, 6+ hour ago   (446+ words) By Matthew Herper and Nathan Vardi This morning, a company that did not exist last summer had the biggest U.S. biotech IPO ever. Axovant Sciences sold shares at $15 a piece, raising $315 million at a $1.4 billion valuation. Already, the stock is up…...


financialcontent.com > article > marketersmedia-2026-10-12-nevada-startup-deviant-cocktail-club-launches-licensed-craft-cocktail-and-zero-proof-subscription-experience

Nevada Startup Deviant Cocktail Club Launches Licensed Craft Cocktail and Zero-Proof Subscription Experience

13+ hour, 42+ min ago   (857+ words) Agave After Hours Introduces the Monthly Concept Agave After Hours introduces customers to Deviant's subscription model through three original tequila-based cocktail recipes and the specialty ingredients needed to prepare 12 drinks. The format reduces the need to purchase full-size bottles of…...


whatnow.com > new-york > local-news > leading-pharmaceutical-company-to-lay-off-205-employees-across-two-new-york-facilities

Leading Pharmaceutical Company to Lay Off 205 Employees Across Two New York Facilities

8+ hour, 2+ min ago   (283+ words) InvaGen Pharmaceuticals, Inc., a New York-based generic drug manufacturer, filed a notice with the New York State Department of Labor on Oct. 8 disclosing that it plans to eliminate 205 positions at two of its facilities beginning November 27. The affected locations are…...


finance.yahoo.com > healthcare > articles > could-merck-mrk-dme-option-180742498.html

Could Merck (MRK) Have A New DME Option After Its Late Stage Trial Data?

6+ hour, 32+ min ago   (371+ words) Merck (NYSE:MRK) reported one year pivotal Phase 2b/3 data for remigromig in diabetic macular edema, showing non inferior efficacy to a leading anti VEGF therapy. The company described remigromig's safety profile in the trial as manageable, supporting its potential use…...


cen.acs.org > business > start-ups > on-our-radar-2026 > 104 > web > 2026 > 10

5 chemistry start-ups on our radar in 2026

9+ hour, 56+ min ago   (167+ words) Federation: Log in through a federation service that connects your organization to multiple systems. Use this option if your organization instructs you to use federated sign-in. These early-stage start-ups are developing chemistry that could reduce our reliance on fossil fuels,…...


telugutimes.net > en > bnews > vestige-marketing-recognized-as-indias-most-desired-direct-selling-brand-2026-363111.html

Vestige Marketing Recognized as India’s Most Desired Direct Selling Brand 2026

11+ hour, 37+ min ago   (222+ words) Telugu Times Leading homegrown direct-selling firm Vestige Marketing Pvt has been recognized as India’s Most Desired Direct Selling Brand 2026 as part of TRA’s Most Desired Brands 2026 report, marking the 12th edition of the prestigious study The study, conducted with…...


pro.thestreet.com > trade-ideas > amid-the-biotech-madness-i-spotted-an-opening-in-a-promising-small-cap

Amid the Biotech Madness, I Spotted an Opening in a Promising Small-Cap

9+ hour, 31+ min ago   (424+ words) Hedge funds dumped genomics plays like this one last week … but it was just as it announced a new AstraZeneca-linked deal. With the bond market closed today, equity action is slow and mixed. Breadth is negative again at about 41% positive,…...